Company Filing History:
Years Active: 2004
Title: Luigi Pellegrini: Innovator in Antitussive Agents
Introduction
Luigi Pellegrini is a notable inventor based in L'Aquila, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitussive agents. His work has led to advancements that benefit both the medical community and patients.
Latest Patents
Pellegrini holds a patent for 1,3-dioxolanes with antitussive activity. This patent, titled "(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals useful as antitussive agents and as intermediates for the preparation of levodropropizine and the salts thereof, as well as a process for the preparation of said acetals," showcases his innovative approach to creating effective cough suppressants.
Career Highlights
Throughout his career, Pellegrini has been associated with Dompé S.p.a., a prominent pharmaceutical company. His work there has allowed him to focus on research and development in the field of antitussive medications. His dedication to innovation has positioned him as a key figure in his area of expertise.
Collaborations
Pellegrini has collaborated with esteemed colleagues such as Marcello Allegretti and Maria Candida Cesta. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.
Conclusion
Luigi Pellegrini's contributions to the field of pharmaceuticals, particularly in antitussive agents, highlight his innovative spirit and dedication to improving healthcare. His work continues to impact the industry positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.